Structure of 2019-nCov RNA polymerase:

https://www.biorxiv.org/content/10.1101/2020.03.16.993386v1.full.pdf+html

/Here we report the cryo-EM structure of 2019-nCoV full-length nsp12 in complex with cofactors nsp7 and nsp8 at a resolution of 2.9-Å...A comparative analysis to show how remdesivir binds to this polymerase is also provided. /

Darren



On 22/03/2020 19:18, Nikolay Dobrev wrote:
Dear all,
I assume most of you are aware of the EMBL-EBI datahub which was set up in January to provide essential virus research data to all scientists, but in case someone missed it I would like to share the link:
https://www.ebi.ac.uk/ena/pathogens/covid-19

You can find all relevant data, from COVID-19 genome sequencing data up to x-ray and cryo-EM structures of relevant proteins.

Stay healthy,
Nikolay

*Nikolay Dobrev *
Scientific Officer, Protein Expression and Purification Core Facility
EMBL Heidelberg, Meyerhofstraße 1, 69117 Heidelberg, Germany
T +49 6221 387 8633 | M +49 173 684 0532
twitter.com/EMBLorg <http://twitter.com/EMBLorg> | facebook.com/embl.org <http://facebook.com/embl.org> | youtube.com/user/emblmedia <http://youtube.com/user/emblmedia> Visit www.embl.org/events <http://www.embl.org/events>for a complete list of all EMBL events.






On Sun, Mar 22, 2020 at 17:26, DUMAS Philippe (IGBMC) <p.du...@ibmc-cnrs.unistra.fr> wrote:

    Relevant to the discussion:

    * Cell, Vol. 110, 551–561, September 6, 2002, Copyright 2002 by
    Cell Press
    An RNA Thermosensor Controls Expression of Virulence Genes in
    Listeria monocytogenes

    * Bacterial RNA thermometers: molecular zippers and switches
    Jens Kortmann and Franz Narberhaus
    NATURE REVIEWS | MICROBIOLOGY VOLUME 10 | APRIL 2012 | 255

    *An RNA Thermometer Activity of the West Nile Virus Genomic
    30-Terminal Stem-Loop Element Modulates Viral Replication Eciency
    during Host Switching
    Viruses 2020, 12, 104; doi:10.3390/v12010104

    * Temperature triggers immune evasion by Neisseria meningitidis
    Edmund Loh1*, Elisabeth Kugelberg2*, Alexander Tracy1, Qian
    Zhang2, Bridget Gollan2, Helen Ewles2, Ronald Chalmers3,
    Vladimir Pelicic2 & Christoph M. Tang1,2
    Nature (2013)

    Philippe Dumas
    ------------------------------------------------------------------------
    *De: *"James Holton" <jmhol...@lbl.gov <mailto:jmhol...@lbl.gov>>
    *À: *"CCP4BB" <CCP4BB@JISCMAIL.AC.UK <mailto:CCP4BB@JISCMAIL.AC.UK>>
    *Envoyé: *Dimanche 22 Mars 2020 16:38:28
    *Objet: *Re: [ccp4bb] CCP4BB vs COVID19

    Thank you Patrick,

    RNA structure is still structural biology, so I think relevant
    here.  It seems to me that RNA as a thermometer would be an easy
    hypothesis to test? Has anyone measured virulence vs temperature
    in cell culture?

    The 3D structure of the genome is no doublt important.  I wouldn't
    want to try crystallizing the whole thing, but I wonder if this
    might be an excellent target for cryoEM?  A challenge for that "we
    can classify our way out of anything" philosophy?  And the result
    would most certainly be interesting.

    -James Holton
    MAD Scientist

    On 3/21/2020 8:41 AM, Patrick Shaw Stewart wrote:


        James, this isn't conventional structural biology, but may be
        of interest, and I haven't been able get any mainstream
        virologists to think about it.

        The protein sequences are obviously of interest, but so are
        the RNA sequences at both ends of the Covid genome, which have
        conserved secondary structure.  A few years ago a paper came
        out suggesting that wild-type influenza has multiple "RNA
        thermometers", which may play an important role in the tropism
        of influenza.  Similar mechanisms may exist in other
        respiratory viruses, including Covid.

        My take on this, and the relevant papers, are below.

        Good luck to everyone and stay well,

        Patrick


            
https://oldwivesandvirologists.blog/Covid-19-and-the-trade-off-model-of-selection/


            My paper in /Medical Hypotheses
            /http://douglas.co.uk/f_ftp1/ShawStewart_final_1-s2.pdf

            Narberhaus, Franz, Torsten Waldminghaus, and Saheli
            Chowdhury. "RNA thermometers." /FEMS microbiology
            reviews/ 30.1 (2006): 3-16.

            Chursov, Andrey, et al. "Specific temperature-induced
            perturbations of secondary mRNA structures are associated
            with the cold-adapted temperature-sensitive phenotype of
            influenza A virus." /RNA biology/ 9.10 (2012): 1266-1274.

            Yang, Dong, and Julian L. Leibowitz. "The structure and
            functions of coronavirus genomic 3′ and 5′ ends." /Virus
            research/ 206 (2015): 120-133.



        On Fri, Mar 20, 2020 at 10:59 PM James Holton
        <jmhol...@lbl.gov <mailto:jmhol...@lbl.gov>> wrote:

            You might think that as a structural biologist you won't
            be able to do
            much about COVID-19 anytime soon, but that is not true. 
            Yes, real-world
            therapeutics and vaccines take time, but we have already
            seen just how
            fast we can get started.  There are 21 PDBs already and
            some even have
            bound ligands.  Good job Frank et al. BTW! And my personal
            thanks to
            all of you out there who are already hard at work on this.

            I believe this forum is an ideal place to share
            information and ideas on
            the structural biology of SARS-CoV-2 as we move forward.
            It's a big
            virus, but there are not that many proteins in it.  If all
            of us
            independently do the same bioinformatics and literature
            searches and end
            up trying exactly the same thing in every lab all over the
            world, then
            that would be more than unfortunate.  To that end, I am
            personally
            interested on ORF8 for reasons I will go into below.  Has
            anyone tried
            to solve it yet?  What happened?  Didn't express? Bad
            diffraction?
            What?  Do tell.

            Some of us, as you may have heard, are stuck at home, our
            beamlines and
            labs dark while we shelter-in-place.  That doesn't mean
            our hands are
            tied.  We are still allowed to think. The fraction of the
            human race
            that has a snowball's chance in Hades of figuring out this
            bug is very
            very small.  Structure may be your main skill set, but you
            are still a
            biologist.  Do you know how to run a PCR machine?  Do you
            know how to
            pipette?  You might think that anybody can do it, but that
            is really not
            the case. Ever trained a new student on sterile
            technique?  How many
            days did that take?  Now remember that your student was no
            dummy and
            already studying biology.  Everyone reading this will make
            an excellent
            volenteer at the very least.  I'm not saying this to
            belittle the
            average human, only to say that we scientists, moving in
            the circles we
            do, often forget that we have uncommon capabilities.

            For example, I also believe we can be useful in assay
            development. The
            void left by the dearth and delay of test results has been
            filled with
            fear, and that is a big problem.  The tests, as defined, are
            straightforward, but also extremely regimented like any
            good laboratory
            protocol should be.  The US CDC's instructions for
            academic labs are here:
            https://www.cdc.gov/coronavirus/2019-nCoV/lab/index.html
            My question is: how can this test be made faster, using
            more commonplace
            supplies, in high-throughput mode and still valid?  Not
            just for
            clinical but for academic use?  I think more than a few
            people on this
            list could be regarded as experts in making a complex
            biochemical task
            faster, more efficient, high-throughput and nonetheless
            valid.  Yes,
            there are other people who do virus testing for a living,
            but right now
            they are all rather busy.  Maybe if we put our minds to it
            we can help?

            As for why ORF8.  I am basing my interest on the
            bioinformatics done in
            this article: https://dx.doi.org/10.1093/nsr/nwaa036.
            Search for
            "T8517C" and you will find what I'm talking about.  The
            authors found
            two "types" of SARS-CoV-2.  They call them "S" and "L"
            because the only
            conserved amino acid change involved is S84L in ORF8.  The
            "S" type is
            believed to be the ancestor of "L".  What is interesting
            is how tightly
            linked this mutation is to a silent mutation on the other
            end of the
            genome: the "L" type has a faster codon for Ser in ORF1. 
            Such tight
            coupling (r^2=0.945) means there must be significant
            selective pressure
            preventing both of these mutations occurring in the same
            virus at the
            same time.  That, I believe, is interesting.  Espeically
            since they are
            so far apart I expect this selective pressure might work
            in trans: as in
            a super-infection. That is, the S and L genome types may
            interfere with
            each other.

            The authors fall short of claiming evidence of
            interference upon
            super-infection, and indeed they have already been
            criticised for
            calling "L" the "aggressive" type.  But it is still
            interesting and
            points a finger at ORF8.

            ORF8 has only one homolog in the PDB: 5o32 with 25%
            identity over a
            stretch of 60 residues.  This homologous region contains
            the S84L site
            (Val I544 in 5o32).  I had a quick look and appears to be a
            cavity-filling mutation to me.  Not very big, but maybe
            something could
            fit in there.  To be sure we'd need a structure of ORF8.

            Good luck to you all, and stay healthy.

            -James Holton
            MAD Scientist

            
########################################################################

            To unsubscribe from the CCP4BB list, click the following link:
            https://www.jiscmail.ac.uk/cgi-bin/webadmin?SUBED1=CCP4BB&A=1



-- patr...@douglas.co.uk <mailto:patr...@douglas.co.uk>   Douglas
        Instruments Ltd.
         Douglas House, East Garston, Hungerford, Berkshire, RG17 7HD, UK
         Directors: Patrick Shaw Stewart, Peter Baldock, Stefan Kolek

        http://www.douglas.co.uk
         Tel: 44 (0) 148-864-9090    US toll-free 1-877-225-2034
         Regd. England 2177994, VAT Reg. GB 480 7371 36



    ------------------------------------------------------------------------
    To unsubscribe from the CCP4BB list, click the following link:
    https://www.jiscmail.ac.uk/cgi-bin/webadmin?SUBED1=CCP4BB&A=1


    ------------------------------------------------------------------------
    To unsubscribe from the CCP4BB list, click the following link:
    https://www.jiscmail.ac.uk/cgi-bin/webadmin?SUBED1=CCP4BB&A=1


------------------------------------------------------------------------

To unsubscribe from the CCP4BB list, click the following link:
https://www.jiscmail.ac.uk/cgi-bin/webadmin?SUBED1=CCP4BB&A=1


--

**********************************************************************

Dr. Darren J. Hart,

CNRS Research Director, Institut de Biologie Structurale (IBS)
Unité Mixte de Recherche UMR5075 (CEA-CNRS-UGA)


Director, Integrated Structural Biology Grenoble (ISBG)
Unité Mixte de Service UMS3518 (CNRS-UGA-CEA-EMBL)

**********************************************************************

Email: darren.h...@ibs.fr
Tel: +33 4 57 42 85 86

Physical address: IBS/ISBG, 71 avenue des Martyrs, 38000 Grenoble, France

Postal address: IBS/ISBG, 71 avenue des Martyrs, CS 20192, 38042 Grenoble, Cedex 9, France

**********************************************************************


########################################################################

To unsubscribe from the CCP4BB list, click the following link:
https://www.jiscmail.ac.uk/cgi-bin/webadmin?SUBED1=CCP4BB&A=1

Reply via email to